The Gross Margin of Sichuan Goldstone Asia Pharmaceutical Inc (300434.SZ) is 61.37%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 61.37% |
2022-12-31 | 61.31% |
2021-12-31 | 56.38% |
2020-12-31 | 53.71% |
2019-12-31 | 64.39% |
2018-12-31 | 65.91% |
2017-12-31 | 63.93% |
2016-12-31 | 34.54% |
2015-12-31 | 39.03% |
2014-12-31 | 39.53% |